Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Star Equity Holdings to Present at the Noble Capital Markets Emerging Growth Virtual Conference on February 4-5
-
Barfresh Announces Preliminary Fiscal Year 2025 Revenue Results and Provides Updated Guidance for Fiscal Year 2026
-
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
-
JP3E Holdings, Inc. Transforms Global Commerce: "Turning Your Imagination into an Economy" Through Web 3.0 and AI
-
GSI Technology Reports 3-Second Time-to-First-Token for Edge Multimodal LLM Inference on Gemini-II
-
Rio Silver Launches Metallurgical Program to De-Risk Processing and Optimize Silver Recoveries at Maria Norte
-
NetraMark Strengthens Board Of Directors
-
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
-
Alliance Entertainment to Host Second Quarter Fiscal Year 2026 Results Conference Call on February 12 at 4:30 p.m. Eastern Time
-
Reborn Coffee Advances China Growth Through Completion of Flagship Presence at Tencent’s New Headquarters Campus in Shenzhen
-
ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center
-
ZenaTech Provides an Update on its Taiwan-Based Spider Vision Sensors Manufacturing Facility Supporting Manufacturing of NDAA-Compliant Drone Components to Meet US Defense Regulations
-
Aether Holdings to Ring Nasdaq Stock Market Closing Bell on Friday, January 30
-
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
-
AA MISSION ACQUISITION CORP. ANNOUNCES RESULTS OF EXTRAORDINARY GENERAL MEETING AND REDEMPTION OF PUBLIC SHARES
-
Global AI Signs Enterprise Contract with One of the World’s Largest Pharmaceutical Companies to Automate Compliance Operations
-
Brazilian Rare Earths December 2025 Quarterly Report
-
Amaze Expands Creator Merchandising with Plushies
-
Olenox Industries Signs Letter of Intent to Acquire Vivakor’s Midstream Business in Oklahoma STACK Play
-
TechForce Robotics BIM-E Serves Over 5,000 Drinks During CES 2026 Debut
-
Apollo Commercial Real Estate Finance, Inc. Announces 2025 Dividend Income Tax Treatment
-
Two XPO Drivers Selected for America’s Road Team
-
Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
-
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
-
DeFi Development Corp. Appoints Hadley Stern to Board of Directors
-
Satellogic Extends Country-Wide Monitoring Agreement with the Government of Albania, Enabling Persistent National Earth Intelligence
-
VelocityEHS Strengthens AI Innovation Leadership with New U.S. Patent
-
Form 8.3 - Life Science REIT Plc
-
TAB Bank Secures a $2.25 Million Asset-Based Lending Facility for Bright Stripes to Create Growth Opportunities
-
Gran Tierra Energy Inc. Provides Operations Update and Certain Preliminary Unaudited 2025 Financial Data
-
Form 8.3 - British Land Co plc
-
Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response Observed on First Scan
-
Gran Tierra Energy Inc. Announces Exchange Offer of Certain Existing Notes for New Notes and the Solicitation of Consents to Proposed Amendments to the Existing Indenture
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference
-
Aprea Therapeutics Announces $5.6 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
-
Fold Chairman and CEO, Will Reeves, Publishes Letter to Fold Customers
-
Verkkokauppa.com to publish its Financial Statements Bulletin 2025 on 12 February 2026
-
Kadant to Acquire voestalpine BÖHLER Profil
-
Stellantis to Present Strategic Plan at May 21 Investor Day
-
Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference
-
Stellantis to Present Strategic Plan at May 21 Investor Day
-
Form 8.3 - IDOX plc - Octopus Investments
-
Statement re Acciaierie d'Italia
-
Statement re Acciaierie d'Italia
-
Command Alkon Showcases the Future of Connected Construction at CONEXPO-CON/AGG 2026
-
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
-
Adaptability emerges as the defining advantage for U.S. business leaders in 2026 – Forvis Mazars C-Suite Barometer
-
Beghou’s Biopharma Commercialization Research Report Reveals Top Challenges, Opportunities, and Investment for Life Sciences Industry in 2026
